{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:03:32Z","timestamp":1792015412482,"version":"4.4.0"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Monogenic Interleukin 1 (IL-1) mediated autoinflammatory diseases (AID) are rare, often severe illnesses of the innate immune system associated with constitutively increased secretion of pro-inflammatory cytokines. Clinical characteristics include recurrent fevers, inflammation of joints, skin, and serous membranes. CNS and eye inflammation can be seen. Characteristically, clinical symptoms are coupled with elevated inflammatory markers, such as C-reactive protein (CRP) and serum amyloid A (SAA). Typically, AID affect infants and children, but late-onset and atypical phenotypes are described. An in-depth understanding of autoinflammatory pathways and progress in molecular genetics has expanded the spectrum of AID. Increasing numbers of genetic variants with undetermined pathogenicity, somatic mosaicisms and phenotype variability make the diagnosis of AID challenging. AID should be diagnosed as early as possible to prevent organ damage. The diagnostic approach includes patient\/family history, ethnicity, physical examination, specific functional testing and inflammatory markers (SAA, CRP) during, and in between flares. Genetic testing should be performed, when an AID is suspected. The selection of genetic tests is guided by clinical findings. Targeted and rapid treatment is crucial to reduce morbidity, mortality and psychosocial burden after an AID diagnosis. Management includes effective treat-to-target therapy and standardized, partnered monitoring of disease activity (e.g., AIDAI), organ damage (e.g., ADDI), patient\/physician global assessment and health related quality of life. Optimal AID care in childhood mandates an interdisciplinary team approach. This review will summarize the current evidence of diagnosing and managing children with common monogenic IL-1 mediated AID.<\/jats:p>","DOI":"10.3389\/fimmu.2021.516427","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T06:44:46Z","timestamp":1616049886000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Management of Monogenic IL-1 Mediated Autoinflammatory Diseases in Childhood"],"prefix":"10.3389","volume":"12","author":[{"given":"Tatjana","family":"Welzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Benseler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin B.","family":"Kuemmerle-Deschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrrheum.2015.114","article-title":"Autoinflammation. Management of hereditary recurrent fevers\u2013SHARE experience","volume":"11","author":"Sarrabay","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.iac.2018.08.004","article-title":"Hereditary autoinflammatory disorders: recognition and treatment","volume":"39","author":"Broderick","year":"2019","journal-title":"Immunol Allergy Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.berh.2017.12.001","article-title":"Periodic fever syndromes","volume":"31","author":"Lachmann","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/978-3-319-98605-0_19","article-title":"Cryopyrin-Associated Periodic Syndromes (CAPS). In: Hashkes PJ, Laxer RM, Simon A, editors","volume-title":"Textbook of Autoinflammation","author":"Hoffmann","year":"2019"},{"key":"B5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/art.37810","article-title":"Hearing loss in Muckle-Wells syndrome","volume":"65","author":"Kuemmerle-Deschner","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1136\/annrheumdis-2013-204184","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"73","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1542\/peds.91.5.915","article-title":"Clinical and biochemical phenotype in 11 patients with mevalonic aciduria","volume":"91","author":"Hoffmann","year":"1993","journal-title":"Pediatrics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1542\/peds.2010-3639","article-title":"Mevalonate kinase deficiency: a survey of 50 patients","volume":"128","author":"Bader-Meunier","year":"2011","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.autrev.2012.07.016","article-title":"Amyloidosis in autoinflammatory syndromes","volume":"12","author":"Obici","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"French","year":"1997","journal-title":"Nat Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever","volume":"90","author":"International","year":"1997","journal-title":"Cell"},{"key":"B13","first-page":"469","article-title":"Familial Hibernian fever","volume":"51","author":"Williamson","year":"1982","journal-title":"Q J Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0092-8674(00)80721-7","article-title":"Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes","volume":"97","author":"McDermott","year":"1999","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1086\/301793","article-title":"Gene localization for an autosomal dominant familial periodic fever to 12p13","volume":"62","author":"Mulley","year":"1998","journal-title":"Am J Hum Genet"},{"key":"B16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-319-98605-0_1","article-title":"Autoinflammation: past, present, and future. In: Hashkes PJ, Laxer RM, Simon A, editors","volume-title":"Textbook of Autoinflammation","author":"Kastner","year":"2019"},{"key":"B17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.revmed.2018.01.004","article-title":"Clinical overview of auto-inflammatory diseases","volume":"39","author":"Georgin-Lavialle","year":"2018","journal-title":"Rev Med Interne"},{"key":"B18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.trsl.2015.06.006","article-title":"Targeting the inflammasome in rheumatic diseases","volume":"167","author":"McCoy","year":"2016","journal-title":"Transl Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.30105","article-title":"The emerging role of interleukin-1\u03b2 in autoinflammatory diseases","volume":"63","author":"Lachmann","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-3-319-98605-0_5","article-title":"Inflammasomes and autoinflammation. In: Hashkes PJ, Laxer RM, Simon A, editors","volume-title":"Textbook of Autoinflammation","author":"Broderick","year":"2019"},{"key":"B22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fimmu.2017.00043","article-title":"The NLRP3 and pyrin inflammasomes: implications in the pathophysiology of autoinflammatory diseases","volume":"8","author":"de Torre-Minguela","year":"2017","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.cdd.4401734","article-title":"Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization","volume":"13","author":"Yu","year":"2006","journal-title":"Cell Death Differ"},{"key":"B24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","article-title":"Proteolytic processing of interleukin-1 family cytokines: variations on a common theme","volume":"42","author":"Afonina","year":"2015","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3389\/fimmu.2017.00344","article-title":"Monogenic autoinflammatory diseases with mendelian inheritance: genes, mutations, and genotype\/phenotype correlations","volume":"8","author":"Martorana","year":"2017","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/9696","article-title":"Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group","volume":"22","author":"Drenth","year":"1999","journal-title":"Nat Genet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/9691","article-title":"Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"22","author":"Houten","year":"1999","journal-title":"Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jaci.2017.02.033","article-title":"Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency","volume":"140","author":"Munoz","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/icb.2016.58","article-title":"Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases","volume":"94","author":"Jurczyluk","year":"2016","journal-title":"Immunol Cell Biol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1002\/art.22194","article-title":"A role for geranylgeranylation in interleukin-1beta secretion","volume":"54","author":"Mandey","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B33","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/ni.3487","article-title":"Control of the innate immune response by the mevalonate pathway","volume":"17","author":"Akula","year":"2016","journal-title":"Nat Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1084\/jem.20102049","article-title":"Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS)","volume":"208","author":"Bulua","year":"2011","journal-title":"J Exp Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/annrheumdis-2012-201952","article-title":"Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS)","volume":"72","author":"Bachetti","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/978-3-319-98605-0_18","article-title":"Tumor Necrosis Factor (TNF) Receptor-Associated Periodic Syndrome (TRAPS). In: Hashkes PJ, Laxer RM, Simon A, editors","volume-title":"Textbook of Autoinflammation","author":"Savic","year":"2019"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/annrheumdis-2011-200549","article-title":"An international registry on autoinflammatory diseases: the Eurofever experience","volume":"71","author":"Toplak","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-319-98605-0_2","article-title":"Genetic aspects of investigating and understanding autoinflammation. In: Hashkes PJ, Laxer RM, Simon A, editors","volume-title":"Textbook of Autoinflammation","author":"Ceccherini","year":"2019"},{"key":"B41","first-page":"756","article-title":"Approach to recurrent fever in childhood","volume":"63","author":"Soon","year":"2017","journal-title":"Can Fam Physician"},{"key":"B42","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.lpm.2018.12.003","article-title":"Autoinflammatory diseases: state of the art","volume":"48","author":"Georgin-Lavialle","year":"2019","journal-title":"Presse Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1136\/annrheumdis-2013-203666","article-title":"Validation of the auto-inflammatory diseases activity index (AIDAI) for hereditary recurrent fever syndromes","volume":"73","author":"Piram","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1002\/art.22491","article-title":"The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model","volume":"56","author":"Aksentijevich","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1182\/blood-2003-07-2531","article-title":"Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA\/NOMID, MWS, and FCU","volume":"103","author":"Neven","year":"2004","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00431-003-1223-x","article-title":"Familial mediterranean fever: revisiting an ancient disease","volume":"162","author":"Ozen","year":"2003","journal-title":"Eur J Pediatr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1002\/art.39763","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"8562485","DOI":"10.1155\/2020\/8562485","article-title":"Clinical features at onset and genetic characterization of pediatric and adult patients with TNF-alpha receptor-associated periodic syndrome (TRAPS): a series of 80 cases from the AIDA network","volume":"2020","author":"Gaggiano","year":"2020","journal-title":"Mediators Inflamm"},{"key":"B49","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1136\/annrheumdis-2015-207701","article-title":"Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases","volume":"75","author":"Rusmini","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e0181874","DOI":"10.1371\/journal.pone.0181874","article-title":"Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis","volume":"12","author":"Omoyinmi","year":"2017","journal-title":"PLoS ONE"},{"key":"B52","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s00296-019-04252-5","article-title":"Diagnostic utility of a targeted next-generation sequencing gene panel in the clinical suspicion of systemic autoinflammatory diseases: a multi-center study","volume":"39","author":"Karacan","year":"2019","journal-title":"Rheumatol Int"},{"key":"B53","doi-asserted-by":"publisher","first-page":"vi44","DOI":"10.1093\/rheumatology\/kez294","article-title":"Current and future advances in genetic testing in systemic autoinflammatory diseases","volume":"58","author":"Schnappauf","year":"2019","journal-title":"Rheumatology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1002\/art.21404","article-title":"Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome","volume":"52","author":"Saito","year":"2005","journal-title":"Arthritis Rheum"},{"key":"B55","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1002\/art.30512","article-title":"High incidence of NLRP3 somatic mosaicism in patients with chronic infantile neurologic, cutaneous, articular syndrome: results of an International Multicenter Collaborative Study","volume":"63","author":"Tanaka","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B56","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1136\/annrheumdis-2014-206844","article-title":"Evidence-based recommendations for genetic diagnosis of familial Mediterranean fever","volume":"74","author":"Giancane","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B57","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1136\/jmedgenet-2017-105216","article-title":"New workflow for classification of genetic variants' pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID)","volume":"55","author":"Van Gijn","year":"2018","journal-title":"J Med Genet"},{"key":"B59","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1002\/humu.20720","article-title":"The infevers autoinflammatory mutation online registry: update with new genes and functions","volume":"29","author":"Milhavet","year":"2008","journal-title":"Hum Mutat"},{"key":"B60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-3-319-98605-0_11","article-title":"Clinical approach to the diagnosis of autoinflammatory diseases","volume-title":"Textbook of Autoinflammation","author":"Hashkes","year":"2019"},{"key":"B61","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","article-title":"Familial Mediterranean fever. A survey of 470 cases and review of the literature","volume":"43","author":"Sohar","year":"1967","journal-title":"Am J Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of familial Mediterranean fever","volume":"40","author":"Livneh","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B64","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","article-title":"A new set of criteria for the diagnosis of familial Mediterranean fever in childhood","volume":"48","author":"Yalcinkaya","year":"2009","journal-title":"Rheumatology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3899\/jrheum.141249","article-title":"Performance of different diagnostic criteria for familial mediterranean fever in children with periodic fevers: results from a multicenter international registry","volume":"43","author":"Demirkaya","year":"2016","journal-title":"J Rheumatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1136\/annrheumdis-2019-215048","article-title":"Classification criteria for autoinflammatory recurrent fevers","volume":"78","author":"Gattorno","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B67","doi-asserted-by":"publisher","first-page":"101729","DOI":"10.3390\/jcm8101729","article-title":"Positive impact of expert reference center validation on performance of next-generation sequencing for genetic diagnosis of autoinflammatory diseases","volume":"8","author":"Boursier","year":"2019","journal-title":"J Clin Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/annrheumdis-2019-eular.3562","article-title":"Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers","volume":"59","author":"Papa","year":"2019","journal-title":"Rheumatology"},{"key":"B69","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1002\/art.40208","article-title":"Clinical and molecular phenotypes of low-penetrance variants of NLRP3: diagnostic and therapeutic challenges","volume":"69","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.clim.2015.01.003","article-title":"A functional inflammasome activation assay differentiates patients with pathogenic NLRP3 mutations and symptomatic patients with low penetrance variants","volume":"157","author":"Rieber","year":"2015","journal-title":"Clin Immunol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/art.21657","article-title":"Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications","volume":"54","author":"D'Osualdo","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B72","first-page":"S2","article-title":"Treat-to-target: rationale and strategies","volume":"30","author":"Smolen","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12969-020-0409-3","article-title":"Consensus protocols for the diagnosis and management of the hereditary autoinflammatory syndromes CAPS, TRAPS and MKD\/HIDS: a German PRO-KIND initiative","volume":"18","author":"Hansmann","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/rheumatology\/kev416","article-title":"Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome","volume":"55","author":"Kuemmerle-Deschner","year":"2016","journal-title":"Rheumatology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1542\/peds.2006-1434","article-title":"Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement","volume":"119","author":"Kallinich","year":"2007","journal-title":"Pediatrics"},{"key":"B77","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.amjmed.2014.12.010","article-title":"Colchicine: old and new","volume":"128","author":"Slobodnick","year":"2015","journal-title":"Am J Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/art.30389","article-title":"Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4\/P-glycoprotein inhibitors","volume":"63","author":"Terkeltaub","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/rheumatology\/kew208","article-title":"Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes","volume":"55","author":"Kullenberg","year":"2016","journal-title":"Rheumatology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1586\/1744666X.2015.1077702","article-title":"Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome","volume":"11","author":"Kone-Paut","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00431-015-2505-9","article-title":"Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience","volume":"174","author":"Kostjukovits","year":"2015","journal-title":"Eur J Pediatr"},{"key":"B82","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/acr.23120","article-title":"International retrospective chart review of treatment patterns in severe familial mediterranean fever, tumor necrosis factor receptor-associated periodic syndrome, and mevalonate kinase deficiency\/hyperimmunoglobulinemia D syndrome","volume":"69","author":"Ozen","year":"2017","journal-title":"Arthritis Care Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2018.1559488","article-title":"Long-term effectiveness and safety of canakinumab in pediatric familial mediterranean fever patients","volume":"2018","author":"Gulez","year":"2018","journal-title":"Mod Rheumatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14397595.2018.1457469","article-title":"Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis","volume":"29","author":"Varan","year":"2019","journal-title":"Mod Rheumatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3899\/jrheum.160518","article-title":"Longterm beneficial effect of canakinumab in colchicine-resistant familial mediterranean fever","volume":"44","author":"Laskari","year":"2017","journal-title":"J Rheumatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jpeds.2010.02.040","article-title":"Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra","volume":"157","author":"Lepore","year":"2010","journal-title":"J Pediatr"},{"key":"B88","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in 10 patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/art.34409","article-title":"Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine 3- and 5-year outcomes","volume":"64","author":"Sibley","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B90","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/art.30149","article-title":"Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome","volume":"63","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B91","doi-asserted-by":"publisher","first-page":"rkz004","DOI":"10.1093\/rap\/rkz004","article-title":"Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review","volume":"3","author":"Garg","year":"2019","journal-title":"Rheumatol Adv Pract"},{"key":"B92","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B95","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1186\/ar4184","article-title":"The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age","volume":"15","author":"Caorsi","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/art.41004","article-title":"Rapid and sustained long-term efficacy and safety of canakinumab in patients with cryopyrin-associated periodic syndrome ages 5 years and younger","volume":"71","author":"Brogan","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/rheumatology\/ket415","article-title":"Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience","volume":"53","author":"Russo","year":"2014","journal-title":"Rheumatology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/ar3266","article-title":"Canakinumab (ACZ885, a fully human IgG1 anti-IL-1beta mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)","volume":"13","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/art.40146","article-title":"Open-label, phase II study to assess the efficacy and safety of canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome","volume":"69","author":"Arostegui","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/art.33416","article-title":"Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study","volume":"64","author":"Bulua","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B101","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/RHU.0b013e31823682f5","article-title":"Effects of anti-tumor necrosis factor agents for familial mediterranean fever patients with chronic arthritis and\/or sacroiliitis who were resistant to colchicine treatment","volume":"17","author":"Bilgen","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/art.30215","article-title":"Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab","volume":"63","author":"Vaitla","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"B103","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/01.RHU.0000442576.41537.de","article-title":"Interleukin 6 blockade for hyperimmunoglobulin D and periodic fever syndrome","volume":"20","author":"Shendi","year":"2014","journal-title":"J Clin Rheumatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/rheumatology\/keu341","article-title":"TLR2\/TLR4-dependent exaggerated cytokine production in hyperimmunoglobulinaemia D and periodic fever syndrome","volume":"54","author":"Stoffels","year":"2015","journal-title":"Rheumatology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"210513","DOI":"10.1136\/bcr-2015-210513","article-title":"Anti-interleukin 6 receptor therapy for hyper-IgD syndrome","volume":"2015","author":"Musters","year":"2015","journal-title":"BMJ Case Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12969-018-0300-7","article-title":"Living with autoinflammatory diseases: identifying unmet needs of children, adolescents and adults","volume":"16","author":"Erbis","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"key":"B107","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12887-019-1458-y","article-title":"From uncertainty to gradually managing and awaiting recovery of a periodic condition- a qualitative study of parents experiences of PFAPA syndrome","volume":"19","author":"Sparud-Lundin","year":"2019","journal-title":"BMC Pediatr"},{"key":"B108","first-page":"156","article-title":"Health-related quality of life, illness perception, coping strategies and the distribution of dependency in autoinflammatory diseases","volume":"37","author":"Cipolletta","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s10067-009-1330-9","article-title":"Depression and anxiety in children and adolescents with familial Mediterranean fever","volume":"29","author":"Makay","year":"2010","journal-title":"Clin Rheumatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/1756-185X.12297","article-title":"Anxiety and depression in adult patients with familial Mediterranean fever: a study comparing patients living in Germany and Turkey","volume":"20","author":"Giese","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"B111","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13023-018-0902-7","article-title":"The patient journey to diagnosis and treatment of autoinflammatory diseases","volume":"13","author":"Hausmann","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B112","first-page":"509","article-title":"Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever","volume":"21","author":"Duzova","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","article-title":"Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers","volume":"147","author":"Kessel","year":"2013","journal-title":"Clin Immunol"},{"key":"B114","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1136\/annrheumdis-2016-210092","article-title":"Development of the autoinflammatory disease damage index (ADDI)","volume":"76","author":"Ter Haar","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1136\/annrheumdis-2018-213725","article-title":"In silico validation of the autoinflammatory disease damage index","volume":"77","author":"Ter Haar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jinf.2010.03.016","article-title":"The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever","volume":"60","author":"Limper","year":"2010","journal-title":"J Infect"},{"key":"B117","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1546-0096-13-S1-P25","article-title":"Genetic and phenotypic characteristics of 114 patients with mevalonate kinase deficiency","volume":"13","author":"Jeyaratnam","year":"2015","journal-title":"Pediatr Rheumatol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/art.39482","article-title":"Brief report: severe inflammation following vaccination against Streptococcus pneumoniae in patients with cryopyrin-associated periodic syndromes","volume":"68","author":"Walker","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/rheumatology\/kex185","article-title":"Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study","volume":"56","author":"Jaeger","year":"2017","journal-title":"Rheumatology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/ard.2011.150193","article-title":"EULAR recommendations for vaccination in paediatric patients with rheumatic diseases","volume":"70","author":"Heijstek","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B121","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s00393-014-1396-x","article-title":"Immunization in children and adolescents with rheumatic and musculoskeletal diseases","volume":"73","author":"Minden","year":"2014","journal-title":"Z Rheumatol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s00103-019-02905-1","article-title":"Impfen bei Immundefizienz : Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen","volume":"62","author":"Wagner","year":"2019","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s00103-018-2761-8","article-title":"Impfen bei Immundefizienz Anwendungshinweise zu den von der St\u00e4ndigen Impfkommission empfohlenen Impfungen. (II) Impfen bei 1. Prim\u00e4ren Immundefekterkrankungen und 2. HIV-Infektion","volume":"61","author":"Ehl","year":"2018","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"B124","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2019","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.516427\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T21:00:37Z","timestamp":1671656437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.516427\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":124,"alternative-id":["10.3389\/fimmu.2021.516427"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.516427","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"article-number":"516427"}}